Skip to main content
Caplight Logo









Visby Medical

Visby Medical

Private
San Jose, CaliforniaHealthcare & Life Scienceshttps://visby.com/

Last Round

Early Funding

Jun 17, 2025

Est. Valuation

$1B

Total Funding Raised

$356.47M

Company Overview

Visby Medical is a diagnostics company that develops single-use handheld PCR-based testing kits for the detection of infectious diseases, including sexual and respiratory health tests.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Telemedicine

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Application

Keywords

PCR testingat-home diagnosticspoint-of-care testingSTI testingfemtechportable PCRrespiratory virus testingdiagnostic hardwareOTC testingover-the-counter testrapid diagnosticstelehealth integrationdisposable test kitsmolecular diagnosticsdigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Visby Medical Comparables

Compare Visby Medical with similar companies based on industry and business-model similarity.

Visby Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aptitude Medical
81%
binx health
81%
Co-Diagnostics, Inc.
78%

Visby Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJun 17, 2025
GrantJan 15, 2025
GrantOct 1, 2023
Series E ExtensionJun 29, 2022
GrantMar 25, 2022
Grant
Feb 2, 2021

Key People

Founding team and executive leadership

Adam de la Zerda

Founder and CEO

Founding Team

Visby Medical Investors

Notable investors and investment history

Visby Medical investors
InvestorRounds
Biomedical Advanced Research and Development Authority (BARDA)Grant
J VenturesSeries E Extension, Grant
CARB-XGrant
Healthcare of Ontario Pension PlanGrant
NIH RADxGrant
+ND CapitalEarly Funding, Grant
J VenturesSeries E Extension, Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 5, 2026

    Developing at-home respiratory pathogen detection tests with Watchmaker Genomics.

  • Feb 5, 2026

    Partnered with Watchmaker Genomics for at-home respiratory tests.

Visby Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Visby Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Visby Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Jose, California
Employee Range182
Year Founded2012
Last FundingJun 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?